Chapter 39 Gonadal Hormones

$2.50

Pay And Download The Complete Chapter Questions And Answers

Chapter 39  Gonadal Hormones

 

 

Complete Chapter Questions And Answers
 

Sample Questions

 

MULTIPLE CHOICE

1. A female patient with a history of endometriosis presents with bilateral lower quadrant pain reportedly at midcycle. Which gonadal drug is indicated for treating symptoms of endometriosis?
A.
Estrogen
B.
Progesterone
C.
Androgens
D.
Gonadotropins

ANS: B

Feedback
A
Estrogen products are used for relieving the hot flash symptoms of menopause; for contraception; for hormone replacement therapy after an oophorectomy; in conjunction with appropriate diet, calcium, and physical therapy in the treatment of osteoporosis; for treatment of severe acne in females; and to slow the disease progress (and minimize discomfort) in patients with advanced prostatic cancer and certain types of breast cancer.
B
Progesterones are used to treat secondary amenorrhea, breakthrough uterine bleeding, and endometriosis. They may be combined with estrogens as contraceptives.
C
Androgens are used to treat hypogonadism, eunuchism, androgen deficiency, and palliation of breast cancer in postmenopausal women with certain cell types of cancer. When androgens are used for palliation of cancer in women, they suppress cancer cell growth.
D
Gonadotropin is a hormone secreted in the pituitary; it regulates the release of the gonadal hormones.

DIF: Cognitive Level: Comprehension REF: 605
TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Physiological Integrity

2. What is the rationale for using an androgen as part of breast cancer treatment?
A.
For maintenance of fat stores
B.
To promote nutrition
C.
To prevent wasting associated secondary to cancer growth
D.
For palliative treatment to suppress cancer cell growth

ANS: D

Feedback
A
Androgens affect muscle growth, not fat stores. Estrogen affects fat stores.
B
Although androgens may be used to stimulate appetite and improve nutrition, this is not the indication in this case.
C
Although androgens may be used to prevent wasting, this is not the indication in this case.
D
When androgens are used for palliation of breast cancer in women, they suppress cancer cell growth.

DIF: Cognitive Level: Comprehension REF: 606
TOP: Nursing Process Step: Implementation
MSC: NCLEX Client Needs Category: Physiological Integrity

3. The health of a patient receiving androgen therapy for breast cancer declines and she becomes bed bound. Which condition will this patient be at risk of developing?
A.
Electrolyte imbalances
B.
Hypercalcemia
C.
Hyperglycemia
D.
Fluid overload

ANS: B

Feedback
A
Immobilization does not affect electrolyte balance.
B
Immobilized patients receiving androgens for palliative breast cancer treatment are at risk for hypercalcemia. The nurse should monitor patients for nausea, vomiting, constipation, poor muscle tone, and lethargy.
C
Immobilization does not affect blood glucose in this case.
D
Immobilization does not affect fluid balance in this case.

DIF: Cognitive Level: Comprehension REF: 606-607
TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Physiological Integrity

4. Which patient on oral contraceptive therapy will be at greatest risk for heart attack?
A.
34-year-old woman with a history of osteoporosis
B.
28-year-old woman with history of eczema
C.
36-year-old woman who smokes half a pack per day
D.
36-year-old woman who has a history of abnormal Pap smears

ANS: C

Feedback
A
Osteoporosis does not increase risk for heart attack.
B
Eczema does not increase risk for heart attack.
C
The incidence of fatal heart attacks is increased for women older than 35 years of age who use gonadal hormones and smoke.
D
Cervical dysplasia does not increase risk for heart attack

DIF: Cognitive Level: Application REF: 602
TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Physiological Integrity

 

There are no reviews yet.

Add a review

Be the first to review “Chapter 39 Gonadal Hormones”

Your email address will not be published. Required fields are marked *

Category: Tag:
Updating…
  • No products in the cart.